Heat-shock proteins (Hsps) are chaperones required for the maintenance of cellular homeostasis in different fungal pathogens, playing an important role in the infectious process. This study investigated the effect of pharmacological inhibition of Hsp90 by radicicol on the Cryptococcus neoformans/Cryptococcus gattii species complex -agents of the most common life-threatening fungal infection amongst immunocompromised patients. The influence of Hsp90 inhibition was investigated regarding in vitro susceptibility to antifungal agents of planktonic and sessile cells, ergosterol concentration, cell membrane integrity, growth at 37 8C, production of virulence factors in vitro, and experimental infection in Caenorhabditis elegans. Hsp90 inhibition inhibited the in vitro growth of planktonic cells of Cryptococcus spp. at concentrations ranging from 0.5 to 2 mg ml 21 and increased the in vitro inhibitory effect of azoles, especially fluconazole (FLC) (P,0.05). Inhibition of Hsp90 also increased the antifungal activity of azoles against biofilm formation and mature biofilms of Cryptococcus spp., notably for Cryptococcus gattii. Furthermore, Hsp90 inhibition compromised the permeability of the cell membrane, and reduced planktonic growth at 37 8C and the capsular size of Cryptococcus spp. In addition, Hsp90 inhibition enhanced the antifungal activity of FLC during experimental infection using Caenorhabditis elegans. Therefore, our results indicate that Hsp90 inhibition can be an important strategy in the development of new antifungal drugs.
INTRODUCTION
The Cryptococcus neoformans/Cryptococcus gattii species complex consists of encapsulated yeasts responsible for cryptococcosis -a deep mycosis that is commonly associated with immunocompromised patients (Coelho et al., 2014) . It is estimated that 1 million annual cases of meningitis caused by Cryptococcus spp. associated with AIDS occur worldwide, resulting in *600 000 deaths (Park et al., 2009 ).
The pathogenesis of cryptococcosis is directly associated with the production of virulence factors by the fungus, such as thermal tolerance at 37 uC, melanin synthesis, enzyme production, biofilm formation and the presence of capsule, the latter being the main attribute for the micro-organism's pathogenesis (Coelho et al., 2014) .
Heat-shock proteins (Hsps) are chaperones that play an important role by helping other proteins to achieve their 3D conformation, especially under various conditions of cellular stress, making them active (Burnie et al., 2006) . It is well known that Hsps are essential regulatory elements of morphogenesis, biofilm formation and antifungal resistance in Candida albicans (Shapiro & Cowen, 2010 , 2012 and Aspergillus fumigatus (Robbins et al., 2011) . Hsps are also essential for yeast-mycelia transition in Histoplasma capsulatum, Coccidioides immitis and Paracoccidioides brasiliensis, as well as in cellular signalling in Cryptococcus neoformans, Fusarium oxysporum and Trichophyton rubrum (Burnie et al., 2006; Tamayo et al., 2013) .
Previous studies have shown that Hsps are important antigens during experimental infection with systemic fungal pathogens (Eroles et al., 1997; Burnie et al., 2006) . In Cryptococcus neoformans, Hsp70 has been described as a major antigen of the humoral response in both murine pulmonary cryptococcosis (Kakeya et al., 1997) and human pulmonary cryptococcosis (Kakeya et al., 1999) . Genetic analyses have also detected the expression of Hsp12, Hsp60, Hsp70 and Hsp90 of Cryptococcus neoformans during experimental meningitis in a murine model (Steen et al., 2003) . Hsps were recognized as one of the components of secretory vesicles in Cryptococcus neoformans (Rodrigues et al., 2008) , and Hsp70 was recently proved to modulate the interaction between Cryptococcus neoformans and human-type alveolar epithelial cells, and to decrease fungal killing by mouse macrophages (Silveira et al., 2013) .
This study aimed to investigate the effect of Hsp90 inhibition on antifungal susceptibility in both planktonic and sessile cells of Cryptococcus spp. In addition, we also evaluated the effect of Hsp90 inhibition on ergosterol concentration, cell membrane integrity, growth rate at 37 uC, production of virulence factors and experimental infection in Caenorhabditis elegans. Hsp90 inhibition was achieved by treatment with radicicol (RAD) -a macrocyclic antifungal that binds specifically to Hsp90.
METHODS
Micro-organisms. Clinical and environmental isolates of Cryptococcus neoformans (n518) and Cryptococcus gattii (n512) were included in this study. Strain identification was performed as described previously (Cordeiro et al., 2013) and included the urease test on Christensen's urea agar (Difco), phenoloxidase activity on birdseed agar (Guizotia abyssinica) supplemented with biphenyl (0.1 %), chemotyping on CGB medium (L-canavanine, glycine and Bromothymol blue), as well as enzymic restriction of the CAP59 gene (Enache-Angoulvant et al., 2007) . All experiments were performed in duplicate. Following identification, a small subset of Cryptococcus strains was chosen for each experimental step described above. Cryptococcus neoformans (n54) and Cryptococcus gattii (n55) strains previously tested for antifungal drugs (Costa et al., 2010; Cordeiro et al., 2013) were included in this study. Throughout this paper we refer to sessile cells attached to a surface as 'biofilms' and refer to cells living in a free-floating form as 'planktonic cells'.
Drugs. RAD (Sigma) was diluted in 50 % DMSO; amphotericin B (AMB), itraconazole (ITC), voriconazole (VRC) and fluconazole (FLC) were prepared according to Clinical and Laboratory Standards Institute guidelines (CLSI, 2008) . Drugs were diluted in RPMI 1640 with L-glutamine (Sigma) without sodium bicarbonate, adjusted to pH 7.0 using 0.165 M MOPS (Sigma).
Inocula preparation. Inocula were prepared from cultures previously grown on potato glucose agar (HiMedia) incubated at 35 uC for 48 h. Suspensions were made in sterile saline (0.9 % NaCl) by adjusting the turbidity to 0.5 on the McFarland scale. The suspension was then diluted with RPMI 1640 medium to obtain an inoculum of planktonic cells containing 0. CLSI (2008) . The MICs for the antifungal drugs were determined as described previously (CLSI, 2008) . For RAD, the MIC was defined as the lowest concentration that inhibited 100 % of visible fungal growth (Cowen et al., 2009 ).
The in vitro interaction between RAD and the antifungal drugs was evaluated in a chequerboard assay (Odds, 2003) . The MIC of each drug in combination (MIC syn ) was defined as the lowest concentration that caused 100 % inhibition of visible fungal growth for the combination with AMB and i50 % inhibition for the combination with the azoles (Nooney et al., 2005) . Drug interactions were classified as synergistic, indifferent or antagonistic according to the fractional inhibitory concentration index (FICI). The interaction was defined as synergistic if FICIj0.5, indifferent if FICIw0.5-4.0 and antagonistic if FICIw4.0 (Odds, 2003) .
Effect of Hsp90 inhibition on biofilm formation and mature biofilm. The effect of Hsp90 inhibition on Cryptococcus spp. strains (n512) biofilms was evaluated according to the protocol designed by Martinez & Casadevall (2006) , with adaptations. Strains were previously evaluated regarding their ability to form biofilms on polystyrene plates by the crystal violet method (Pierce et al., 2008) . Fungal strains capable of producing biofilms were grown on potato glucose agar for 48 h at 35 uC. After this time, cells were suspended in RPMI 1640 until reaching turbidity corresponding to 4 on the McFarland scale. Aliquots of 100 ml inoculum were transferred to flat wells of 96-well polystyrene plates containing 100 ml RPMI 1640 and incubated for 48 h at 35 uC under stirring at 80 r.p.m. After this period, 200 ml aliquots of each test solution were added to mature biofilms.
To analyse the effect of RAD and antifungal drugs on biofilm formation, 100 ml aliquots of fungal inoculum were added to flat wells containing 100 ml each test solution and incubated as described above. Antifungals were tested at both the MIC and 10| MIC; RAD was tested only at the MIC. Drug combinations were formed by RAD at the MIC plus antifungals at both the MIC and 10| MIC. Controls were grown in medium without antimicrobials. The viability of biofilms was evaluated using the XTT [2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide] assay and the A 492 was determined (Martinez & Casadevall, 2006) .
Effect of Hsp90 inhibition on ergosterol concentration. Total sterols were extracted as described by Moran et al. (2007) with modifications. Cryptococcus spp. strains (n54) were cultured in RPMI 1640 containing RAD and FLC at the MIC; drugs were tested alone and in combination. Tubes were incubated for 48 h at 35 uC and then the culture was centrifuged at 13 200 g for 3 min. The pellets were suspended in 500 ml alcoholic KOH (3.945 g KOH and 40 ml sterile distilled water, brought to 100 ml with 100 % ethanol) and incubated for 1 h at 95 uC. After this period, the total sterols were extracted by adding 600 ml n-hexane and vortexed for 5 min. The tubes were then centrifuged at 9998 g for 1 min, and the entire top organic layer was transferred to a new tube and mixed with 1000 ml n-hexane. A 295 was determined and the results were compared with the ergosterol content of cells grown in RPMI 1640 medium without drugs.
Effect of Hsp90 inhibition on cell membrane integrity. The effect of Hsp90 inhibition on cell membrane integrity was analysed as described by Devi et al. (2010) , with modifications. Inocula of Cryptococcus spp. strains (n54) were prepared as described above for susceptibility testing and the cells were incubated in RPMI 1640 medium at a ratio of 1 : 20 containing each test solution for 48 h at 35 uC. Cells were tested against RAD, FLC and RAD+FLC at the MIC; controls were grown in medium without antimicrobials. Cells were then collected by centrifugation at 13 416 g for 15 min and aliquots of supernatant were diluted 1 : 10 in distilled water. A 260 and A 260 were determined for nucleic acids and proteins, respectively.
Effect of Hsp90 inhibition on growth at 37 8C. The effect of Hsp90 inhibition on growth of Cryptococcus spp. strains (n54) at 37 uC was assessed according to Jones & Murphy (1998) , with modifications. Fungal cells were subcultured twice on potato glucose agar and incubated at 30 uC for 48 h. Cell suspensions were then made in sterile saline by adjusting the turbidity to 4 on the McFarland scale (1-2|10 7 cells ml 21 ). A total of 400 ml inoculum was transferred to RPMI 1640 medium at a ratio of 1 : 10 supplemented with RAD at the MIC. Cells were incubated in water bath at 37 uC and at time intervals of 0, 6, 24, 48 and 72 h, 100 ml aliquots of each culture were plated on Petri dishes containing potato glucose agar to enable c.f.u. counts. The positive control consisted of cells without RAD treatment.
Effect of Hsp90 inhibition on capsule production. Capsule induction was performed as suggested by Frases et al. (2008) , with adaptations. Cryptococcus spp. strains (n54) were cultured on potato glucose agar for 48 h at 35 uC and then the cells were suspended in sterile saline at a turbidity of 4 on the McFarland scale. Aliquots of 100 ml inoculum were transferred to sterile tubes containing 1 ml capsule-inducing medium (15 mM glucose, 10 mM MgSO 4 , 29.4 mM KH 2 PO 4 , 13 mM glycine, 3 mM thiamine-HCl, pH 5.5) and 100 ml RAD (MIC), FLC (MIC) or RAD+FLC (MIC); controls were grown in media without antimicrobials. Tubes were incubated for 48 h at 35 uC, after which the slides were prepared with India ink and observed under an optical microscope. The diameters of the capsules of 50 cells in a total of 10 fields for each sample were measured with the help of cellSens 2011 software (Olympus). The volume of the capsules produced was calculated based on the difference of the total volume of the cell with the capsule minus the volume of the cell, according to Zaragoza & Casadevall (2004) , using:
where D 1 is the overall diameter of the cell with the capsule and D 2 is the diameter of blastoconidia (Zaragoza & Casadevall, 2004) .
Effect of Hsp90 inhibition on protease production. The effect of Hsp90 inhibition on Cryptococcus spp. protease production was detected using azoalbumin as substrate (Charney & Tomarelli, 1947) . Cryptococcus spp. strains (n54) (10 6 cells ml 21 ) were cultured under stirring at 80 r.p.m. in RPMI 1640 medium containing RAD, FLC, VRC, RAD+FLC or RAD+VRC at the MIC, during 5 days at 35 uC. After incubation, aliquots were collected and centrifuged at 2292 g for 10 min. The supernatant was mixed with 0.3 % azoalbumin and the mixture was incubated at 37 uC for 3 h. The enzymic reaction was stopped by adding 5 % trichloroacetic acid. Aliquots were centrifuged at 9167 g for 10 min and 1 ml supernatant was mixed with 1 ml 0.5 M NaOH. A 440 was determined in an Epoch spectrophotometer (BioTek). Counting of c.f.u. ml 21 was performed after each incubation interval. Controls were formed by Cryptococcus cultures in RPMI 1640 medium without antimicrobials. All experiments were conducted in duplicate.
Effect of Hsp90 inhibition on melanin production. The effect of Hsp90 inhibition on Cryptococcus spp. melanin production was determined as described by Ngamskulrungroj & Meyer (2009) , with modifications. Cells of Cryptococcus spp. strains (n54) were incubated in YEPD broth (2 % glucose, 2 % peptone and 1 % yeast extract) at 35 uC for 24 h. Cells were resuspended in sterile saline and suspensions were adjusted to 4 on the McFarland scale. Aliquots of 10 ml were then added to 1700 ml melanin induction broth (YNB with 1 % glucose, without amino acids and ammonium sulfate) with RAD at the MIC. Melanin production was induced with 200 ml L-DOPA at 10 mM. After incubation at 30 uC for 48 h, aliquots were centrifuged at 1378 g for 5 min. A 475 of the supernatants was read in a spectrophotometer. Controls were performed with melanin induction broth without L-DOPA and with L-DOPA and without RAD. All experiments were conducted in duplicate.
Effect of Hsp90 inhibition on Caenorhabditis elegans killing.
The effect of Hsp90 inhibition was investigated in experimental infection using the nematode Caenorhabditis elegans, according to the protocols proposed by Breger et al. (2007) , with adaptations. Nematodes in L4 stage were previously cultured in nematode growth medium with Escherichia coli OP50. Cryptococcus spp. strains (n52) were previously cultured in brain heart infusion agar (BHI; HiMedia) supplemented with 100 mg ciprofloxacin ml 21 for 48 h at 35 uC. E. coli strain OP50 was also previously grown for 24 h at 30 uC in BHI broth without antibiotic and was used as control. The worms were then transferred by washing with M9 buffer to plates containing the microorganisms. Plates were maintained at 25 uC for 2 h, allowing the nematodes to feed. After this period, the nematodes were subjected to three consecutive washes with BHI broth for removal of microorganisms attached to their cuticle. Approximately 50 worms were then transferred to wells in a six-well microtitre dish that contained 1.5 ml liquid medium composed of 79 % M9 buffer, 20 % BHI, cholesterol in ethanol (10 mg ml
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) and ciprofloxacin (100 mg ml
). RAD was tested alone (MIC) or combined with FLC (MIC). The plates were incubated at 25 uC, and nematode survival was analysed after 0, 24, 48, 72 and 96 h. Worms were considered dead if fungal structures were externalizing from the pseudocoelom of the nematode and/or there was no response to mechanical stimuli (Breger et al., 2007) . Dead worms were removed from the wells throughout the experiment.
Statistical analysis. The results were evaluated by ANOVA and means were compared by Tukey's post-test. For the survival curve, the Kaplan-Meier, log-rank and Wilcoxon tests were used to detect differences between groups. Pv0.05 was considered significant for all evaluations. Statistical analyses were performed using Prism 5.0 (GraphPad).
RESULTS

Susceptibility testing of planktonic cells
RAD inhibited the growth of Cryptococcus spp., with MIC values ranging from 0.5 to 2 mg ml 21 for Cryptococcus gattii and 1 to 2 mg ml 21 for Cryptococcus neoformans (Table 1 ). The selected strains showed reduced susceptibility to AMB (MICw1.0 mg ml 21 , n51) and FLC (MICi64 mg ml 21 , n55), as shown in Table 1 . Antifungal susceptibility results of internal controls Cryptococcus neoformans (CEMM 05-2-076, CEMM 03-2-063, CEMM 05-1-050 and CEMM 03-2-060) and Cryptococcus gattii strains (CEMM 03-2-070, CEMM 03-2-074, CEMM 05-2-082, CEMM 03-2-069 and CEMM 03-2-073) were as expected, except for minor deviations regarding azole results.
Concerning the interaction testing, RAD significantly reduced (Pv0.05) the MICs of azoles for both Cryptococcus neoformans and Cryptococcus gattii strains. For these drug combinations, synergism was observed for the majority of tested strains. MICs of antifungal drugs were reduced eight-to 64-fold for ITC, eight-to 64-fold for FLC and eight-to 32-fold for VRC. Synergism with AMB was observed for only one strain of Cryptococcus neoformans and three strains of Cryptococcus gattii. Antagonism was not observed for any drug combination (Tables 2 and S1 , available in the online Supplementary Material). Based on the synergistic effect between RAD and FLC, this antifungal drug was chosen for further experimentation.
Effect of Hsp90 inhibition on Cryptococcus biofilms
When tested alone, RAD was not able to prevent the formation of Cryptococcus biofilms (Pw0.05). Regarding antifungals, AMB, VRC and FLC (10| MIC) interfered with biofilm formation in Cryptococcus neoformans; only AMB (10| MIC) affected biofilm formation in Cryptococcus gattii (Pv0.05). However, combinations formed by RAD and all tested antifungals interfered with biofilm formation in Cryptococcus spp. (Pv0.05) (Fig. S1 ). In general, combinations formed by RAD and antifungals were more 
Effect of Hsp90 inhibition on cell membrane integrity, ergosterol concentration and growth
RAD induced changes in membrane permeability of Cryptococcus cells, causing the release of proteins for Cryptococcus gattii. Escape of nucleic acids, however, was not detected (Fig. S3) . At the MIC, RAD did not reduce cell ergosterol concentration of Cryptococcus spp. (Pw0.05) (Fig. S4) . Treatment with RAD reduced the survival of Cryptococcus cells at 37 uC (Pv0.05). A c.f.u. reduction was detected after 24 and 6 h for Cryptococcus neoformans and Cryptococcus gattii, respectively (Fig. 1) .
Effect of Hsp90 inhibition on capsular volume
RAD alone or in combination with FLC reduced the capsular volume of Cryptococcus spp. (Pv0.05). For Cryptococcus neoformans, RAD was more efficient than FLC or RAD+FLC (Pv0.05). Greater reduction of Cryptococcus gattii capsules was seen with the RAD+FLC combination (Pv0.05), as seen in Figs 2 and S5.
Effect of Hsp90 inhibition on protease and melanin production
Treatment with RAD alone or combined with antifungals did not interfere in protease production of Cryptococcus (Fig. S6) . The presence of L-DOPA stimulated melanin production in Cryptococcus, but Hsp90 inhibition was not able to reduce melanin production (Fig. S7) .
Effect of Hsp90 inhibition on Caenorhabditis elegans killing
Treatment with RAD alone or combined with FLC decreased the virulence of Cryptococcus in experimental infection with Caenorhabditis elegans (Pv0.05) (Fig. 3) . When tested alone, RAD increased the survival of nematodes by 18.67 % against Cryptococcus neoformans (Fig. 3a) and 4.66 % against Cryptococcus gattii (Fig. 3b) , when compared with the untreated control. As for FLC 
DISCUSSION
Although there are no studies on the antifungal activity of RAD against Cryptococcus spp., it is well known that this drug has antifungal activity against many fungal pathogens, such as Candida albicans, Paracoccidioides brasiliensis, Aspergillus fumigatus, Fusarium avenaceum and Mucor flavus (Fujita et al., 1999; Nicola et al., 2008; Chen et al., 2011; Kang et al., 2014) . These studies have shown that RAD inhibits fungal growth at concentrations ranging from 0.365 to 50 mg ml
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In the present study, we showed that RAD inhibited Cryptococcus growth at concentrations that ranged from 0.5 to 2 mg ml 21 and also enhanced the inhibitory effect of FLC against Cryptococcus spp. Studies with Candida albicans (Shapiro et al., 2012) and A. fumigatus (Lamoth et al., 2012) have shown that the inhibition of Hsp90 also prevents the growth of those species. In addition, Hsp90 blocking modulates fungal morphogenesis, virulence, biofilm development and antifungal resistance, particularly to azoles and echinocandins. Hsp90 also regulates responses to stress in the membrane that are critical to the survival of the fungus in the presence of azoles (Shapiro & Cowen, 2012; Shapiro et al., 2012) , corroborating the results of our research.
We found that the inhibitory action of ITC, VRC and FLC against the biofilms produced by Cryptococcus spp. was enhanced by the inhibition of Hsp90, especially for Cryptococcus gattii. The fact that Cryptococcus gattii was more responsive to the blocking of Hsp90 is particularly important as this fungus is often identified as a primary pathogen, causing disease that is usually thought to represent recent infection, whilst Cryptococcus neoformans cryptococcosis is usually thought to result from reactivation of latent infection, frequently in human immunodeficiency virusinfected and other severely immunocompromised individuals (Harris et al., 2014) .
Hsp90 is a key regulatory protein in biofilm dispersion and phenotype resistance to antifungal agents in sessile cells of Candida albicans and A. fumigatus. The genetic depletion of Hsp90 reduces the in vitro development and maturation of biofilms produced by Candida albicans, and the cell dispersion after maturation of biofilms is impaired. In addition, the impediment of Hsp90 action was found to decrease resistance of Candida albicans biofilms against azoles and A. fumigatus biofilms against echinocandins, in vitro and in vivo (Robbins et al., 2011) . These findings are supported by our results, as Hsp90 blocking increased the inhibitory effect of azoles against Cryptococcus spp. biofilms.
In the present study, we showed that RAD-treated cells had lower c.f.u. counts compared with control cells, which may be related to a reduced growth rate. Interestingly, RAD treatment also reduced the capsular volume of Cryptococcus cells, although it had no effect on melanin production and proteolytic activity. A previous study conducted by On: Tue, 08 Jan 2019 15:39:29 Cordero et al. (2013) showed that capsular enlargement in Cryptococcus neoformans cells was proportional to the growth rate. According to the authors, capsular growth is an important energy-demanding process and, in general, it occurs prior to the first cell replication event. It is well known that the induction of the capsule and melanin synthesis are regulated by a common cAMP pathway, which controls the expression of many genes at the transcriptional level (Pukkila-Worley et al., 2005) . The presence of other genes involved in melanin synthesis which are not controlled by cAMP pathway as well as the auto-oxidation of melanin precursors (Pukkila-Worley et al., 2005) could help to explain the continued melanin production in Cryptococcus cells without capsules detected in our study.
Previous studies have described the interaction between FLC and Cryptococcus capsules. Vitale et al. (2012) showed that capsulated cells presented high FLC MICs in comparison with non-capsulated cells. Santos et al. (2014) showed that FLC impaired glucuronoxylomannan synthesis, decreasing the capsular thickness and altering the physical and structural properties of Cryptococcus gattii capsules. In the present study, FLC was able to reduce the capsular volume of Cryptococcus neoformans and Cryptococcus gattii, and its action was enhanced by the inhibition of Hsp90. This result may be clinically relevant as the capsule is the most important virulence factor of Cryptococcus.
In addition, we explored the effect of Hsp90 blocking in an experimental infection model using the nematode Caenorhabditis elegans. The inhibition of Hsp90 reduced the virulence of Cryptococcus spp. and increased the action of FLC, amongst the main results of our study. It is known that Cryptococcus neoformans is highly pathogenic against this nematode, and that the capsule and virulence genes are required during infection in Caenorhabditis elegans, as in mammal models also (Mylonakis et al., 2002) . These findings are corroborated by decreased capsular volume and virulence against Caenorhabditis elegans through Hsp90 blocking evidenced in our study.
Therefore, the present study showed that the inhibition of Hsp90 by RAD inhibits the in vitro growth of planktonic cells of Cryptococcus spp. Additionally, Hsp90 inhibition enhances the in vitro effect of the main antifungal drugs used in the treatment of cryptococcosis, especially FLC. As in planktonic cells, inhibition of Hsp90 improves the in vitro effect of antifungals against biofilm formation and mature biofilms of Cryptococcus spp., particularly for Cryptococcus gattii. Furthermore, Hsp90 inhibition compromises the permeability of the cell membrane, reduces the growth at 37 uC and the capsular volume, and increases the effect of FLC in vitro and in vivo in an experimental infection model using Caenorhabditis elegans. Therefore, Hsp90 is an important target for the development of antifungal strategies. 3 . Survival of Caenorhabditis elegans after feeding for 2 h on strains of (a) Cryptococcus neoformans (n51) and (b) Cryptococcus gattii (n51). Nematodes were infected and then moved to pathogen-free liquid media in the presence of RAD or FLC, at the MIC, RAD (MIC) + FLC (MIC), or PBS (control). Dead worms were counted and removed daily. Data are expressed as mean¡SEM. Significant differences amongst groups of each species: *P,0.05; **P,0.0002; ***P,0.0001.
